PYocrNEs are bacteriocines produced by strains of Pseudomonas aeruginosa and inhibitory to other strains of the same species. They may be classified in two main groups on the basis of their molecular weight. The high molecularweight group (mol. wt. 106-107) is composed of two types of particle: the contractile and the filamentous, both visible in the electron microscope and apparently similar to certain defective bacteriophages. The structure and activity of these pyocines have been described in detail by several workers (Kageyama, 1964;Higerd, Baechler and Berk, 1967;Takeya et al., 1969; Govan, 1974a and b). The other major group of pyocines consists of substances of lower molecular weight (c. lo*), which are not sedimentable by ultracentrifugation and have not been resolved in the electron microscope, but are apparently simple proteins resembling some colicines (Ito, Kageyama and Egami, 1970;Ohkawa, Kageyama and Egami, 1973). These pyocines are known as S type or small.
P. aeruginosa poses considerable problems in hospitals because it readilyattacks debilitated patients and, because of its resistance to many antibiotics, treatment of infections is difficult. The specific inhibitory activity of pyocines is well documented and recently the therapeutic use of these agents has been suggested.Bird and Grieble (1969) injected an infective dose of P. aeruginosa into chick embryos, followed immediately by a suitable pyocine preparation, and found that a single dose of pyocine increased the survival of infected embryos from 3 % to 46 %. Similarly, Merrikin and Terry (1972) recorded an improvement in survival of mice infected with P. aeruginosa and treated intravenously with pyocine. However, it is difficult to assess the future of pyocine therapy from these reports, because neither group of workers purified the pyocine preparations, nor did they define clearly the type of pyocine used.The aim of this investigation was to examine the therapeutic use of a representative of each of the three types of pyocine in infections caused by a single sensitive strain of P . aeruginosa.
MATERIALS AND METHODSBacterial strains. P. aeruginosa strain P14 was kindly supplied by Dr R. J. Jones, Birmingham Accident Hospital, and was used throughout as the pyocine-sensitive indicator and Govan, 1966) and has a distinctive inhibition pattern. The other strains of P. aeruginosawere from the collection in the Bacteriology Department, Edinburgh University Medical School.One-hundred and seventy strains of P. aeruginosa